recombinant DNA technology
英
美 [rɪˈkɑmbɪnənt ˌdiː en ˈeɪ tekˈnɑːlədʒi]
网络 DNA重组技术; 技术; 重组DNA技术; 重组; 重组 DNA技术
双语例句
- The advent of recombinant DNA technology has provided efficient and cost-effective alternate sources for many therapeutic proteins.
重组DNA技术为许多治疗性蛋白的生产提供了一种有效的替代方法。 - Certain APIs of low molecular weight, such as antibiotics, amino acids, vitamins, and carbohydrates, can also be produced by recombinant DNA technology.
有些低分子量的原料药，如抗生素、氨基酸、维生素和糖类也可以用重组DNA来生产。 - Although the traditional amino acid producing methods such as chemical synthesis and isolation from natural sources are still utilized, the most significant trend in amino acid production technique is the swift and violent development of multiple method and biological synthesis, especially the application of recombinant DNA technology.
生物资源提取、化学合成、生物合成和综合法是生产氨基酸的4种技术，目前的发展趋势为生物合成和综合法，特别是将现代生物工程技术应用于氨基酸生产。 - Therapeutic recombinant proteins are produced by the recombinant DNA technology.
重组药用蛋白质是指利用DNA重组技术生产的蛋白质。 - This highly interdisciplinary field is closely associated with both the physical and chemical properties of organic and inorganic nanoparticles, as well as to the various aspects of molecular cloning recombinant DNA and protein technology, and immune-ology.
这种新颖的交叉跨度很高的化学学科与有机／无机纳米粒子的物理化学性质，以及分子克隆，DNA重组，蛋白质技术和免疫学有着非常紧密的联系。 - In this study, recombinant DNA technology was applied for producing recombinant human BMP-4 mature peptide.
因此本研究利用基因工程生产人BMP-4成熟肽。 - This paper introduced the expression of BMP in Pichia Pastoris using recombinant DNA technology, determined the phenotype of X-33/ pPICZ α A-BMP, optimized the growth conditions and expression conditions.
文章介绍了利用基因工程技术在酵母菌中表达BMP的方法，对构建的Pichiapastoris酵母工程菌株X-33/pPICZαA-BMP进行了发酵表达，确定了菌株的表型、高密度生长及表达条件。 - Prophylactic vaccines based on the use of virus-like particles ( VLPs) obtained from auto-assembly of L1 or L1 and L2 proteins produced by recombinant DNA technology are under phase I/ II clinical trials for HPV6/ 11 associated with condylomas.
通过DNA重组技术，基于HPV6/11型L1或L1和L2蛋白自我组装成病毒样颗粒的研究已经进入了I/II期临床实验。 - With the development of recombinant DNA technology and expression system, quantity of known protein increases.
随着重组DNA技术的发展和表达体系的完善，已知的蛋白质数目有了很大增长。 - With the development of recombinant DNA and peptide synthesize technology, and advantage in analytical separation technology, more and more proteins and peptides, such as enzyme, activators and inhibitors, poly-and monoclonal antibodies, and various vaccines, are used as pharmaceuticals in clinic.
随着重组DNA和多肽合成技术的发展，更加之分析分离技术的提高，越来越多的蛋白质和多肽，象酶、活性因子、抑制因子、多克隆与单克隆抗体、疫苗，被作为药物应用于临床。